Holen Sie sich die Stockscreener-App
133.51
0.87%
-1.17
Handel nachbörslich:
133.00
-0.51
-0.38%
Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
23.53%
150.04
|
121.46 | 118.77 | 104.76 | 87.17 |
Operating Expenses
|
4.66%
186.76
|
178.44 | 191.38 | 167.39 | 165.21 |
| Interest Income/Expense |
22.29%
-4.086
|
-5.258 | - | - | - |
| Benefits Costs and Expenses |
10.01%
198.97
|
180.88 | 193.59 | 169.36 | 166.51 |
| Costs And Expenses |
4.66%
186.76
|
178.44 | 191.38 | 167.39 | 165.21 |
| Operating Income/Loss |
35.57%
-36.71
|
-56.98 | -72.62 | -62.62 | -78.05 |
| Income/Loss From Continuing Operations Before Tax |
17.64%
-48.93
|
-59.41 | -74.83 | -64.60 | -79.34 |
| Income Tax Expense/Benefit |
-0.96
|
- | 0.085 | - | - |
| Income/Loss From Continuing Operations After Tax |
19.26%
-47.97
|
-59.41 | -74.91 | -64.60 | -79.34 |
|
Net Income/Loss
|
19.26%
-47.97
|
-59.41 | -74.91 | -64.60 | -79.34 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.17%
49.44
|
48.87 | 0.2107 | 48.14 | 47.57 |
| Diluted Average Shares |
1.17%
49.44
|
48.87 | 0.2107 | 48.14 | 47.57 |
| Basic Earnings Per Share |
20.49%
-0.97
|
-1.22 | -1.54 | -1.34 | -1.67 |
| Diluted Earnings Per Share |
20.49%
-0.97
|
-1.22 | -1.54 | -1.34 | -1.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.28%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):